Investing
Bausch & Lomb’s stock soars 9% after earnings beat
Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat revenue guidance…
Your best advisor to finance and money management.
Explaining Finance is your one-stop website for the latest news, updates, and tips about finance.
Latest News
Mastercard’s stock sinks toward worst day in 2 years after earnings
Mastercard Inc. shares were falling toward their worst day in two years Thursday as investors appeared uneasy with the company’s…
Private equity: Everything you always wanted to know about this $12 trillion asset class but were afraid to ask
Whether you’re a stock-market investor, an employee of a private business or a customer of one of the thousands of…
Apple, Amazon and Microsoft’s bonds shrug off equity weakness as Nasdaq falls into correction territory
Meta Platforms Inc.’s stock was down 5% Thursday to lead the Magnificent Seven group lower, but its bonds were again…
Bitcoin Prices Stand Firm as the Stock Market Dips
Bitcoin prices hit their highest level since May 2022 amid a rally this week. Dreamstime Bitcoin and other cryptocurrencies advanced…
Dogecoin leads increases as large cryptocurrencies start mixed
Large cryptocurrencies were mixed during morning trading on Thursday, with Dogecoin DOGEUSD, -1.66% seeing the biggest move, rising 5.50% to…
Truist raising $1.75B in bond offering, making it the latest bank to raise capital
Truist Financial Corp. is pricing a $1.75 billion bond offering with strong demand on Wednesday, a source in the bond…
Hasbro’s stock is having its worst month since the 1980s as toys sales tumble
Shares of Hasbro Inc. got rocked Thursday, making investors suffer through the worst month in four decades, as a weakening…
Morgan Stanley’s new CEO Ted Pick has ‘big shoes to fill’ as he faces challenging markets, analyst says
Ted Pick, Morgan Stanley’s incoming chief executive, faces multiple challenges — including having a tough act to follow in James…
University endowments fail when compared with the stock market. Here’s one reason.
The 60/40 stock-bond portfolio, given up for dead in recent years, is outperforming almost all the sophisticated endowment portfolios at…
Opinion: The stock market is looking for direction and there’s a hopeful sign just ahead
The stock market, as measured by the S&P 500 Index SPX, is testing its support level at 4200, which is…
Bitcoin had a nice rally, but don’t expect it to test all-time highs for at least a year
Welcome back to Distributed Ledger. This is Frances Yue, reporter at MarketWatch. Bitcoin BTCUSD, -0.07% had an impressive rally this…
More office zombies? Only 11% of maturing loans repay in September, Moody’s Analytics says
New financing for old office loans that Wall Street packed into bond deals years ago has been getting more scarce,…
Three Overlooked Companies Ready To Soar Post-Stock Market Fall
When markets fall, it often triggers emotional and financial distress among investors. This discomfort arises not only from the direct…
Here’s how a government shutdown in November would likely impact stocks
Stock market investors need not worry about the impact of a possible U.S. government shutdown in mid-November. That’s the conclusion…
6 Scary Money Stats To Be Aware Of
Halloween is a time for getting together, carving pumpkins, dressing up, and telling scary stories. Your finances can be part…
Why America’s Once-Beloved 60/40 Strategy Remains Loaded With Peril
The traditional 60/40 investment portfolio, a staple of American retirement planning, has been taking a beating since the start of…
Oil prices mark first gain in 4 sessions as risks of market disruptions in the Middle East remain
Oil prices finished higher on Wednesday, buoyed by renewed worries over the potential for market disruptions in the Middle East,…
Abbott Laboratories to Submit Limb-Threatening Ischemia Drug to FDA Review
By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects…